ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1948

TNF-α Overrides the Ability of RANK Ligand to Induce Osteoclast Differentiation of Classical Circulating Precursors

Cecilia Ansalone1, Flavia Sunzini1, Caitlin Duncan1, Sabarinadh Chilaka1, Iain B. McInnes2 and Carl S. Goodyear3, 1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom, 3Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: bone disease, Dendritic cells, monocytes, osteoclastogenesis and tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Biology and Pathology of Bone and Joint Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

TNF-α is well known to be involved in inflammatory-induced bone destruction. This is widely supported by clinical studies showing reduced bone pathology after anti-TNF-α therapies. Numerous in vivo and in vitro studies in rodents have demonstrated that TNFα directly contributes to osteoclast(OC)-mediated joint destruction. Moreover, specific murine OC precursors are expand during inflammatory arthritis. Despite this, it is still unclear which population within the human myeloid compartment primarily contributes to OC-mediated bone erosion, and whether or not TNF-α has a direct impact on all pre-cursors equally. Here we have investigated the direct effect of TNF-α on different circulating myeloid populations and their subsequent differentiation into osteoclasts.

Methods: Total CD14+ monocytes, monocyte subsets (CD14+CD16–, CD14+CD16+, CD14dimCD16+), and myeloid dendritic cell precursors (pre-DCs; CD16–CD14–CD11c+) were isolated from peripheral blood of healthy donors using either magnetic separation or FACS. Selected populations were differentiated into OC with M-CSF and RANK-L in the presence or absence of TNF-α. Mature OCs were stained with tartrate-resistant acid phosphatase and quantified by light microscopy. Mineral-coated surfaces were used to assess the resorption activity of mature OCs. Flow cytometry analysis was used to assess surface protein expression during OC differentiation. Antibody blocking studies and selective inhibition of IKK-β were performed to determine the role of TNFR1 and TNFR2 in OC development. Gene expression was assessed by RT-qPCR.

Results: Simultaneous stimulation of CD14+ monocytes with RANK-L and TNF-α resulted in complete abolishment of OC differentiation and resorption. Notably, these cells acquired a macrophage phenotype. In contrast, delayed addition of TNF-α (72h pre-stimulation with RANKL) enhanced osteoclast numbers. Importantly, CD14+ monocytes expressed both TNFR1 and TNFR2 but only the level of TNFR1 decreased during OC differentiation. Blockade of TNFR1 negated the inhibitory capacity of simultaneous TNF-α whilst blockade of TNFR2 reverted the enhancing capacity of TNF-α. Inhibition of IKK-β revealed that the TNFR1-driven inhibitory signal was dependent on the canonical NF-κB pathway. At a molecular level, TNF-α signalling in CD14+ monocytes blocked the M-CSF-driven up-regulation of RANK transcript.

In comparison to CD14+ monocytes, pre-DCs differentiated quicker and more efficiently into OCs under M-CSF and RANK-L stimulation. Interestingly, pre-DCs were found to express less TNFR1 than CD14+ monocytes and TNF-α failed to inhibit RANK expression and thus their differentiation into functional OCs.

Conclusion: We have shown that the hierarchy between TNF-α and RANK-L is crucial for driving the differentiation of CD14+ monocytes into either macrophage or osteoclasts. In comparison, this axis does not influence the ability of pre-DCs to differentiate down the OC lineage. This study provides new insight in the contribution of different circulating myeloid precursors to bone destruction in a TNF-α rich environment.


Disclosure: C. Ansalone, None; F. Sunzini, None; C. Duncan, None; S. Chilaka, None; I. B. McInnes, None; C. S. Goodyear, None.

To cite this abstract in AMA style:

Ansalone C, Sunzini F, Duncan C, Chilaka S, McInnes IB, Goodyear CS. TNF-α Overrides the Ability of RANK Ligand to Induce Osteoclast Differentiation of Classical Circulating Precursors [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/tnf-%ce%b1-overrides-the-ability-of-rank-ligand-to-induce-osteoclast-differentiation-of-classical-circulating-precursors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tnf-%ce%b1-overrides-the-ability-of-rank-ligand-to-induce-osteoclast-differentiation-of-classical-circulating-precursors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology